Fatigue
Conditions
Brief summary
A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of 'Ursa Complex Soft Cap. (UDCA-004)' in patients with physical fatigue.
Interventions
DRUGUrsodeoxycholic acid, taurine, ginsenoside, thiamine, inositol
DRUGPlacebo
Sponsors
Daewoong Pharmaceutical Co. LTD.
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* CIS greater than or equal to 76, HADS less than or equal to 10
Exclusion criteria
* Subjects who have diseases that can cause fatigue * Subjects who are taking medication that can cause fatigue
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of subjects whose CIS score has improved under 76 at week 4 | 4 weeks |
Countries
South Korea
Outcome results
None listed